Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo. - Wikidata - awgldk - TriplyDB

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

http://www.wikidata.org/entity/Q35223458

about

Intelligent design: combination therapy with oncolytic viruses From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer Cytokine synergy: an underappreciated contributor to innate anti-viral immunity A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers.Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production.Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors.Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.Biological effects of a de novo designed myxoma virus peptide analogue: evaluation of cytotoxicity on tumor cells.Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.Oncolytic Poxviruses.Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma.Oncolytic virotherapy for pancreatic cancer.Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer.ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeutic.Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor-resistant multiple myeloma On the potential of oncolytic virotherapy for the treatment of canine cancers.Oncolytic myxoma virus: the path to clinic Myxoma virus therapy for human embryonal rhabdomyosarcoma in a nude mouse model.Cytokine determinants of viral tropism.The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.The current status and future directions of myxoma virus, a master in immune evasion.Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.Targeting autophagy to enhance oncolytic virus-based cancer therapy.Intratumoral immunotherapy for melanoma.Investigation of cytotoxicity of negative control peptides versus bioactive peptides on skin cancer and normal cells: a comparative study.The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.Tumor-Localized Secretion of Soluble PD1 Enhances Oncolytic Virotherapy.Myxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumors.Potential of oncolytic viruses in the treatment of multiple myeloma.Oncolytic virus and PD-1/PD-L1 blockade combination therapy Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma

P2860

Q24628227-FC476759-C836-4232-89C2-779F0A96CD18 Q26822694-E63DBCB5-CAA1-412A-A601-FB4B359A76D7 Q26852421-065560E7-60D0-446D-B035-A2185FAD02F7 Q33554262-C383CCEE-EF32-4070-AD7B-E2172C08E007 Q33613734-0D7A6503-2B8C-41E3-A2BC-513AB96096CC Q33667768-59548715-A249-4403-BD33-709CC6225BF6 Q33808504-57AFE286-0B24-4F4F-9A3C-68EF04A3E901 Q33895494-96FB6437-AFAA-4FEE-91C8-3EB9CAEC595E Q33924550-ACF7CD55-FBD9-49B5-8D87-0D18D2510984 Q33931640-644E8C22-4335-4D76-81AE-E7D610E59B0B Q34031478-EEED6D24-9C33-4B68-B772-850B2063E153 Q34351517-092AADBF-535A-4230-B6E2-50392EEF0F64 Q34819569-9A782DFD-85C4-4C15-9062-886CF5452A48 Q35216344-D5288B27-AC46-4A7F-B217-BD33562D4881 Q35234349-02DC1ACD-A6D0-4F20-BDEB-5B9E1E13EE1C Q35317396-89CA92A6-D08C-4ED6-8EBC-A342B77A8BE2 Q35590996-7088CB32-FA3B-4DE0-B13D-7325FD3DB8EA Q35876172-B55FB2E4-0450-4EB9-9BBF-067F83B41B19 Q36014043-03AE425F-25E3-4FD7-A14A-F74943435C62 Q37031914-28559FA9-A02F-47E2-9A52-B551CD3AEED7 Q37031925-ADA8CAB3-E319-47D4-AC61-E19FF8B8BB51 Q37126088-CBADE7F5-5AFF-4B70-8D48-2D4159A1FE8E Q37200546-A9DE1F56-9C37-42E6-8726-11BBE726C8B6 Q37583568-9A47E3F7-35B8-4E41-8DB2-EE75A914F994 Q37787452-46EA3B5E-5749-4338-8FA2-335A2958955F Q37887080-AC721CF3-1BD1-4E66-B02D-CD42CCF59C0C Q37899223-11BB82CC-5115-4FEA-B45D-D02E12180786 Q38089106-E58314F3-FA53-40EA-99A6-2EE6466E15D2 Q38518518-637CB1CD-ADCB-4293-AF1F-B26C4DFA287E Q39292187-E5369267-C532-4388-BD3C-0B9FED6BC579 Q39703425-F06D6A55-B99C-4590-9EFA-3E2BA5C88F07 Q39995833-293942E7-F7D9-49F9-9EF7-C47BA0AA5B0A Q40287020-4892E7FE-DBEB-4591-AC9C-E7A46BC53237 Q42118566-AF02B928-DC5D-4EB6-9A75-BF4221F70CC4 Q52674773-948DCD3B-664B-47BD-B9FC-45ACFD0F7594 Q57174025-A03A98EE-7B33-4391-B036-8C2D25CBE946 Q58711851-DF9227F6-E62F-4FD2-B166-49EE340FD383 Q59117175-00E1415C-2596-4021-927A-16FEE93448BA

P2860

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

http://www.wikidata.org/entity/Q35223458

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

@ast

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

@en

type

label

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

@ast

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

@en

prefLabel

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

@ast

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

@en

P1433

Q35223458-3A34356C-7AFA-485E-AA8D-29DA403679D3

P1476

Q35223458-69FBEB82-775F-4BF4-93D3-1938CECF7AF8

P2093

Q35223458-1BFBEB87-8E4D-44F0-8354-7B61095B004F

Q35223458-54BF1F12-36FC-4A83-B47D-33A3A1C1A421

Q35223458-563ECE04-5FFA-40F9-8013-FF38194B0F11

Q35223458-5A2A3476-E1DF-4679-8DB1-7F154F5F6305

Q35223458-A43AA33E-1A78-49AF-B9A8-CD8A86899069

Q35223458-F2C3F760-400C-4660-A006-266DCB5F1786

Q35223458-F688CF4C-6292-4B01-B85A-746DF64E4DDD

P2860

Q35223458-00079850-9132-4F39-B398-9A8B74AC3936

Q35223458-10EF5B18-BABA-4F7F-AF25-B2D9966E901D

Q35223458-16908B1C-8DCA-41DD-B725-31A740D98AD5

Q35223458-1AA2D6EA-5A61-44E8-A717-8D8DD2793683

Q35223458-1B0FB95F-6E95-4B7A-8B52-44521C8C80A9

Q35223458-1C2DAE0B-C2A3-4640-ADEE-37404799FE99

Q35223458-266AAD05-11C9-4AAA-9DBF-18225A9174A7

Q35223458-2F782FC4-7CA2-4DC3-8413-EB6FF4AF73B2

Q35223458-34B6426F-4D0F-450E-95E7-4BBD787D7B86

Q35223458-3A7EE73C-2594-4899-8C58-88BE367201E4

P304

Q35223458-F5A90FBC-4345-4647-9894-EE37CB20D899

P31

Q35223458-92A1CF2B-6976-41EF-8D48-5A981F5FB150

P356

Q35223458-4D60DAB5-CC61-4240-BD96-4A03B07EAB73

P433

Q35223458-77B04BD0-AFCD-44F1-9C9D-AB01437DB9A3

P478

Q35223458-4829D795-A69F-4DE0-B5C2-5F37DB256BE3

P50

Q35223458-8438849B-5126-4E28-96DB-A9E83C810DA6

Q35223458-8DF97795-034D-4BD7-B3B5-D85C39767357

Q35223458-E1068E92-D341-4262-BBC3-7ED685A8D82D

P577

Q35223458-021A57EE-2517-4F3F-B93A-05E7370189A6

P698

Q35223458-CA769E36-5866-4FA3-820F-FF372A002134

P932

Q35223458-B053D046-273F-46C7-9059-37F1FF1CA756

P356

P1433

Molecular Therapy

P1476

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo

@en

P2093

Joe Bondy-Denomy

http://www.w3.org/2001/XMLSchema#string

John W Barrett

http://www.w3.org/2001/XMLSchema#string

Kevin C Graham

http://www.w3.org/2001/XMLSchema#string

Lisa Mackenzie

http://www.w3.org/2001/XMLSchema#string

Mae Shaban

http://www.w3.org/2001/XMLSchema#string

Philippe-Alexandre Gilbert

http://www.w3.org/2001/XMLSchema#string

Steven J Werden

http://www.w3.org/2001/XMLSchema#string

P2860

Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

Poxvirus tropism

The Complete DNA Sequence of Myxoma Virus

Dissemination and growth of cancer cells in metastatic sites

Ras, PI(3)K and mTOR signalling controls tumour cell growth

Adventures with poxviruses of vertebrates.

Viral oncolysis.

Viral oncolysis by herpes simplex virus and other viruses.

Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.

Oncolytic viruses: programmable tumour hunters.

P304

52-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.MT.6300348

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Ann F. Chambers

Marianne Stanford

P577

2007-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17998900

http://www.w3.org/2001/XMLSchema#string

P932

4376281

http://www.w3.org/2001/XMLSchema#string